Journal of Obesity & Metabolic Syndrome·Jan 19Amylin Revisited: A 5-Year Perspective on Its Emerging Role in the Treatment of DiabesityReviewInterventionsPaper
Revista Espanola de Anestesiologia y Reanimacion·Jan 16GLP1 receptor analogues and perioperative management considerations: A narrative reviewReviewGLP-1 receptor agonistsPaper
Current Obesity Reports·Jan 13Pharmacological Management of Diabesity: Current and Emerging TherapiesReviewInterventionsPaper
Drug, Healthcare and Patient Safety·Jan 8Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset MethodStudy of 67,305 peopleTirzepatidePaper
Cardiovascular Diabetology·Dec 25Glucagon-like peptide-1 receptor agonists and risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulationCohort study of 2,384 peopleGLP-1 receptor agonistsPaper
Molecular Metabolism·Dec 12Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: Preclinical development and phase 1 randomized ascending dose studiesRandomized trial in 85 peopleType 2 diabetesPaper
Cureus·Dec 10Severe Small-Bowel Obstruction in a High-Risk Patient on Long-Term Tirzepatide Therapy: A Case ReportCase reportTirzepatidePaper
European Journal of Clinical Investigation·Dec 2Muscle health in the modern era of incretin-based therapiesReviewMusclePaper
Mayo Clinic Proceedings·Dec 1GLP1 and GIP Receptor Agonists: Effects on the Gastrointestinal Tract and Management Strategies for Primary Care PhysiciansReviewGLP-1 receptor agonistsPaper
Drug Design, Development and Therapy·Nov 22The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A ReviewReviewGLP-1 receptor agonistsPaper
Cardiology in Review·Nov 18Bimagrumab: Novel Medical Therapy for Inclusion Body Myositis, Sarcopenia, and Medication-Induced Lean Body Mass LossReviewSarcopeniaPaper
Frontiers in Surgery·Nov 17Effect of exercise prescription intervention mode in the Omaha System in elderly patients with delayed gastric emptying after choledocholithiasis surgeryNon-randomized trial in 96 peopleExercisePaper
AHA Scientific Sessions 2025 Abstract·Nov 3Evaluating Procedural Safety and Outcomes In GLP-1 Exposed Patients Undergoing TEECohort study of 9,668 peoplePopulationsPaper
Cureus·Oct 28Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis: A Narrative ReviewReviewSemaglutidePaper
Journal of Diabetes and Metabolic Disorders·Oct 28Psychological and behavioral effects of GLP-1 and GIP agonists in weight loss: a comprehensive reviewReviewGLP-1 receptor agonistsPaper
EJIFCC·Oct 16Inflammation: The Mother of All Diseases Meets the Mother of All TherapiesReviewInterventionsPaper
Experimental Gerontology·Sep 17Variations in oral performance and processing behaviours among older adults: Associations with gastric emptying, postprandial glucose and insulin responsesStudy in peoplePopulationsPaper
Nanoscale·Aug 29Cloudberry-derived nanovesicles as stable oral drug delivery systems: gastrointestinal stability and age-related biodistribution in miceExperiments in miceInterventionsPaper
Current Opinion in Pulmonary Medicine·Aug 22Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apneaReviewGLP-1 receptor agonistsPaper
International Journal of Molecular Sciences·Aug 11GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis ManagementReviewGLP-1 receptor agonistsPaper
Frontiers in Pharmacology·Jul 1A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatideSystematic reviewTirzepatidePaper
ADA Scientific Sessions 2025 Abstract·Jun 13Effect of Combined Therapy with Once-Weekly Subcutaneous Cagrilintide 2.4 mg and Semaglutide 2.4 mg (CagriSema) on Energy Intake, Gastric Emptying, and Appetite in Adults with Overweight or ObesityRandomized trial in 62 peopleCagrilintide + semaglutidePaper
Pathology, Research and Practice·Apr 26The critical role of GLP-1 signaling pathways in the pathology of Parkinson's disease and diabetesReviewParkinson's diseasePaper
Current Opinion in Obstetrics & Gynecology·Apr 4The use of GLP-1: receptor agonist medications for benign gynecologyReviewGLP-1 receptor agonistsPaper
Food Research International·Feb 19Microbial protease supplementation improves gastric emptying and protein digestive fate of beef for the elderly under dynamic in vitro digestionExperiments in cellsGut and microbiomePaper
Biochimica et Biophysica Acta Molecular Basis of Disease·Feb 2Amylin is incorporated into extracellular vesicles in an ESCRT-dependent manner and regulates senescenceExperiments in cellsCellular senescencePaper
Diabetes, Metabolic Syndrome and Obesity·Jan 31Appendicitis After Initiation of TirzepatideCase reportTirzepatidePaper
The American Journal of Medicine·Jan 31Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy RegulationReviewGLP-1 receptor agonistsPaper